Results
|
22101.
|
|
|
22102.
|
|
|
22103.
|
|
|
22104.
|
|
|
22105.
|
|
|
22106.
|
Protection and antibody responses to oral priming by attenuated human rotavirus followed by oral boosting with 2/6-rotavirus-like particles with immunostimulating complexes in gnotobiotic pigs. [electronic resource] by
- Nguyen, T V
- Iosef, C
- Jeong, K
- Kim, Y
- Chang, K-O
- Lovgren-Bengtsson, K
- Morein, B
- Azevedo, M S P
- Lewis, P
- Nielsen, P
- Yuan, L
- Saif, L J
Producer: 20040325
In:
Vaccine vol. 21
Availability: No items available.
|
|
22107.
|
|
|
22108.
|
Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. [electronic resource] by
- Yu, Xiaocong
- Tsibane, Tshidi
- McGraw, Patricia A
- House, Frances S
- Keefer, Christopher J
- Hicar, Mark D
- Tumpey, Terrence M
- Pappas, Claudia
- Perrone, Lucy A
- Martinez, Osvaldo
- Stevens, James
- Wilson, Ian A
- Aguilar, Patricia V
- Altschuler, Eric L
- Basler, Christopher F
- Crowe, James E
Producer: 20081030
In:
Nature vol. 455
Availability: No items available.
|
|
22109.
|
|
|
22110.
|
|
|
22111.
|
|
|
22112.
|
Enterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice. [electronic resource] by
- Gu, Jiang
- Liu, Yanqing
- Yu, Shu
- Wang, Haiguang
- Wang, Qingxu
- Yi, Yong
- Zhu, Fengcai
- Yu, Xue-Jie
- Zou, Quanming
- Mao, Xuhu
Producer: 20091016
In:
Microbes and infection vol. 11
Availability: No items available.
|
|
22113.
|
|
|
22114.
|
|
|
22115.
|
|
|
22116.
|
Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice. [electronic resource] by
- Pachlopnik Schmid, Jana
- Ho, Chen-H
- Chrétien, Fabrice
- Lefebvre, Juliette M
- Pivert, Gérard
- Kosco-Vilbois, Marie
- Ferlin, Walter
- Geissmann, Frédéric
- Fischer, Alain
- de Saint Basile, Geneviève
Producer: 20100526
In:
EMBO molecular medicine vol. 1
Availability: No items available.
|
|
22117.
|
|
|
22118.
|
Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial. [electronic resource] by
- Wu, Jiang
- Fang, Han-Hua
- Chen, Jiang-Ting
- Zhou, Ji-Chen
- Feng, Zi-Jian
- Li, Chang-Gui
- Qiu, Yuan-Zheng
- Liu, Yan
- Lu, Min
- Liu, Li-Ying
- Dong, Shan-Shan
- Gao, Qiang
- Zhang, Xiao-Mei
- Wang, Nan
- Yin, Wei-Dong
- Dong, Xiao-Ping
Producer: 20090814
In:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 48
Availability: No items available.
|
|
22119.
|
|
|
22120.
|
|